EGCG also inhibited NLRP3 inflammasome activation by reducing NLRP3 expression and production of active caspase-1, IL-1β, and IL-18 in NZB/W F1 lupus-prone mice [86]. This evidence concerns the gene IL1B and systemic lupus erythematosus.